For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Group 2 | Fab antivenom followed by placebo maintenance therapy | 0 | None | 0 | 4 | 0 | 4 | View |
| Group 3 | Placebo initial and maintenance therapy | 0 | None | 0 | 4 | 0 | 4 | View |
| Group 1 | Fab Antivenom followed by Fab antivenom maintenance | 0 | None | 0 | 5 | 1 | 5 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Acute hypersensitivity reaction | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Hypotension | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Tachycardia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |